Emerging drugs for the treatment of major depressive disorder-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Emerging drugs for the treatment of major depressive disorder

Published:2022-07-03 Issue:3 Volume:27 Page:263-275
ISSN:1472-8214
Container-title:Expert Opinion on Emerging Drugs
language:en
Short-container-title:Expert Opinion on Emerging Drugs

Author:

Hong Jennifer¹,Vernon Darian¹,Kunovac Jelena²,Stahl Stephen³

Affiliation:

1. Department of Psychiatry, University of California Riverside School of Medicine, Riverside, CA, USA

2. Department of Psychiatry, University of Nevada Las Vegas, Las Vegas, NA, USA

3. Department of Psychiatry, University of California, San Diego, CA, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728214.2022.2117297

Reference78 articles.

1. Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice

2. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

3. The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018)

4. Depression

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioequivalence Study of Vortioxetine Hydrobromide Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions;Drug Design, Development and Therapy;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP